Indegene IPO
Indegene Ltd

₹14,916 / 33 shares

RHP/DRHP

Issue Date

--

Price Range

₹430 - ₹452

Lot Size

33

IPO Size

₹1842.65 Cr

Indegene IPO Listing Details

Listing On

13 May'24

Issue Price

₹452

Listed Price

₹ 655

Retail Gain/Listing Gain

44.91%

Schedule of Indegene IPO

Start date

End date

Allotment of bids

Refund Initiation

Listing on exchange

13/05/2024

Tune in to know more about the company, IPO issue details, product/service portfolio, and much more with Kinjal Parekh!
Indegene IPO Review | Issue Price | Price Band | Life Science

Kotak Neo

3m 02s

Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.

The company's services can be divided into the following categories:

  1. Enterprise Commercial Solutions

  2. Omnichannel Activation

  3. Enterprise Medical Solutions

  4. Enterprise Clinical Solutions and consultancy services

  • Indegene relies on sub-contractors and third-party service providers, who may not perform their obligations satisfactorily in compliance with the law, and Indegene may have no recourse against such sub-contractors and service providers.

  • Indegene's international operations are exposed to complex management, legal, tax, and economic risks, and exchange rate fluctuations, which could adversely affect business, financial condition, and results of operations.

  • Most of Indegene's revenue comes from its subsidiaries, so any disruptions in one or more of them could negatively impact the company's business, financial condition, and operational results.

Key Strategies

  • Strengthen the “go to market” engine

  • Develop technology portfolio

  • Pursue strategic acquisitions

Loading chart...
Here's a video playlist to help you invest in the upcoming Indegene Limited IPO
How to apply for IPO through ASBA

Kotak Neo

04m 01s

Here are the steps to apply for Indegene Ltd IPO:

Step 1: Log in to your Kotak Neo Demat account Log in to your Demat account to access IPO investments. Next, select the current IPO section.

Step 2: Specify IPO details Enter the number of lots and the price you wish to apply for.

Step 3: Enter UPI ID After entering your UPI ID, click submit. This will place your bid with the exchange.

Step 4: Mandate Notification Your UPI app will receive a mandate notification to block funds.

Step 5: Approve Request Your funds will be blocked once you approve the mandate request on your UPI.

The Indegene IPO opens for subscription from [-] to [-], with a total issue size of ₹1842.65 Cr. The IPO price band is ₹430 to ₹452 per share with a lot size of 33. The company aims to list the shares on BSE & NSE on 13-05-2024.

The Indegene IPO will open for subscription on [-] and will close on [-] for investors.

The minimum lot size for the Indegene IPO is 33 equity shares, requiring a minimum investment of ₹14916 for retail investors applying in the IPO.

The price band of the Indegene IPO has been fixed at ₹430 to ₹452 per equity share.

You can apply for the Indegene IPO online through the Kotak Neo Website or the Kotak Neo App using UPI or ASBA during the IPO subscription period.

Indegene IPO allotment will take place on [-].

You can check the Indegene IPO allotment status online on the registrar’s website or on the NSE and BSE IPO allotment pages using your application number, PAN, or demat account details.

Indegene shares will list on the stock exchanges on 13-05-2024.

You can find detailed information about the Indegene IPO, including its business operations, financial performance, risk factors, and IPO objectives, in the Draft or Red Herring Prospectus (RHP).

The Indegene Limited IPO has an issue size of Rs. 1,842 Cr. The IPO opens for subscription on 6th May 2024 and closes on 8th May 2024.

Link Intime India Private Limited is the registrar for this IPO.

Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO.